Beta Bionics, Inc. - Common Stock (BBNX)

CUSIP: 08659B102

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
44,038,904
Total 13F shares
48,310,134
Share change
+3,173,949
Total reported value
$959,915,542
Price per share
$19.87
Number of holders
127
Value change
+$85,339,869
Number of buys
84
Number of sells
37

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 08659B102?
CUSIP 08659B102 identifies BBNX - Beta Bionics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BBNX - Beta Bionics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Zone Healthcare Holdings, LLC
13D/G
Dapice Joshua J.
9.9%
4,313,920
$85,717,590 +$17,618,729 30 Sep 2025
MORGAN STANLEY
13D/G 13F
Company
8.6%
3,739,567
$74,305,196 +$16,109,185 30 Sep 2025
EVENTIDE ASSET MANAGEMENT, LLC
13F 13D/G
Company
11%
from 13D/G
4,932,351
$71,828,898 30 Jun 2025
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
9.5%
4,203,920
$61,209,075 30 Jun 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
8.9%
3,901,599
$56,683,621 30 Jun 2025
13F
Soleus Capital Management, L.P.
13F
Company
8.7%
3,820,158
$55,621,500 30 Jun 2025
13F
BlackRock, Inc.
13D/G 13F
Company
6.4%
2,778,764
$55,215,708 $0 30 Sep 2025
Sands Capital Alternatives, LLC
13F
Company
8.1%
3,570,113
$51,980,845 30 Jun 2025
13F
Sands Capital Life Sciences Pulse Fund II, L.P.
13D/G
8.2%
3,570,113
$48,410,732 +$5,636,946 30 Jun 2025
RTW INVESTMENTS, LP
13F
Company
7.5%
3,299,191
$48,036,221 30 Jun 2025
13F
Omega Fund Management, LLC
13F
Company
4.5%
1,988,287
$28,949,459 30 Jun 2025
13F
PERCEPTIVE ADVISORS LLC
13F 13D/G
Company
3.7%
from 13D/G
1,593,608
$23,202,932 30 Jun 2025
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.7%
1,168,415
$17,012,122 30 Jun 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
2.6%
1,159,737
$16,885,771 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
1.8%
796,964
$15,835,993 -$29,602,207 30 Sep 2025
Divisadero Street Capital Management, LP
13F
Company
2.2%
948,965
$13,816,930 30 Jun 2025
13F
ArrowMark Colorado Holdings LLC
13F
Company
2.1%
925,363
$13,473,300 30 Jun 2025
13F
Holocene Advisors, LP
13F
Company
1.8%
770,851
$11,223,591 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
1.6%
706,968
$10,293,455 30 Jun 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.5%
665,653
$9,691,908 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
1.4%
614,965
$8,953,891 30 Jun 2025
13F
Vestal Point Capital, LP
13F
Company
1.2%
550,000
$8,008,000 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
1.2%
539,963
$7,861,861 30 Jun 2025
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.1%
500,000
$7,280,000 30 Jun 2025
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.01%
2,500
$6,247,987 30 Jun 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
0.95%
419,398
$6,106,000 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.72%
317,943
$4,630,000 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.71%
312,930
$4,557,108 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.71%
311,001
$4,528,175 30 Jun 2025
13F
Clearbridge Investments, LLC
13F
Company
0.57%
249,734
$3,636,127 30 Jun 2025
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.55%
244,202
$3,555,581 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.52%
229,995
$3,348,727 30 Jun 2025
13F
Walleye Capital LLC
13F
Company
0.5%
218,189
$3,176,832 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.49%
216,349
$3,150,041 30 Jun 2025
13F
Longaeva Partners L.P.
13F
Company
0.45%
196,607
$2,862,598 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.44%
193,325
$2,814,812 30 Jun 2025
13F
First Turn Management, LLC
13F
Company
0.36%
157,194
$2,288,745 30 Jun 2025
13F
Woodline Partners LP
13F
Company
0.28%
125,000
$1,820,000 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.23%
102,225
$1,488,396 30 Jun 2025
13F
UBS Group AG
13F
Company
0.22%
96,061
$1,398,649 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.22%
95,253
$1,386,883 30 Jun 2025
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Company
0.2%
89,105
$1,297,369 30 Jun 2025
13F
Alyeska Investment Group, L.P.
13F
Company
0.17%
75,000
$1,092,000 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.16%
72,245
$1,051,887 30 Jun 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.16%
70,175
$1,021,747 30 Jun 2025
13F
Bellevue Group AG
13F
Company
0.15%
66,825
$972,972 30 Jun 2025
13F
JENNISON ASSOCIATES LLC
13F
Company
0.13%
59,185
$861,733 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.13%
55,433
$807,105 30 Jun 2025
13F
Ghisallo Capital Management LLC
13F
Company
0.11%
50,000
$728,000 30 Jun 2025
13F
Verition Fund Management LLC
13F
Company
0.1%
45,476
$662,131 30 Jun 2025
13F

Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) as of Q3 2025

As of 30 Sep 2025, Beta Bionics, Inc. - Common Stock (BBNX) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,310,134 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Soleus Capital Management, L.P., MORGAN STANLEY, Sands Capital Alternatives, LLC, RTW INVESTMENTS, LP, BlackRock, Inc., VANGUARD GROUP INC, and Omega Fund Management, LLC. This page lists 127 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
114
Q3 2025 holders
127
Holder diff
13
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.